Therefore, we speculated that the renal benefits of SGLT2 inhibitors in kidneys with non-diabetic CKD might be the result of a reduction of hyperfiltration in functional nephrons, hereby reducing mechanical stress and glomerular damage. Here, SLC5A2 is linked to chronic kidney disease.